S
Silvio Cavuto
Researcher at Academy for Urban School Leadership
Publications - 86
Citations - 4171
Silvio Cavuto is an academic researcher from Academy for Urban School Leadership. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 27, co-authored 73 publications receiving 3386 citations. Previous affiliations of Silvio Cavuto include Mario Negri Institute for Pharmacological Research & University of Florence.
Papers
More filters
Journal ArticleDOI
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Carlo Salvarani,Giovanni Dolci,Marco Massari,Domenico Franco Merlo,Silvio Cavuto,Luisa Savoldi,Paolo Bruzzi,Fabrizio Boni,Luca Braglia,Caterina Turrà,Pier Ferruccio Ballerini,Roberto Sciascia,Lorenzo Zammarchi,Ombretta Para,Pier Giorgio Scotton,Walter O Inojosa,Viviana Ravagnani,Nicola Duccio Salerno,Pier Paolo Sainaghi,Alessandro Brignone,Mauro Codeluppi,Elisabetta Teopompi,Maurizio Milesi,Perla Bertomoro,Norbiato Claudio,Mario Salio,Marco Falcone,Marco Falcone,Giovanni Cenderello,Lorenzo Donghi,Valerio Del Bono,Paolo Luigi Colombelli,Andrea Angheben,Angelina Passaro,Giovanni Secondo,Renato Pascale,Ilaria Piazza,Nicola Facciolongo,Massimo Costantini +38 more
TL;DR: This randomized clinical trial of hospitalized adult patients with COVID-19 pneumonia and Pao2/Fio2 ratio between 200 and 300 mm Hg who received tocilizumab found no benefit on disease progression was observed compared with standard care, and further blinded, placebo-controlled randomized clinical trials are needed.
Journal ArticleDOI
Quality of Cancer Pain Management: An Update of a Systematic Review of Undertreatment of Patients With Cancer
Maria Teresa Greco,Anna Roberto,Oscar Corli,Silvia Deandrea,Elena Bandieri,Silvio Cavuto,Giovanni Apolone +6 more
TL;DR: Analysis of 46 articles published from 1994 to 2013 using the PMI to assess the adequacy of analgesic therapy suggests the quality of pharmacologic pain management has improved, however, approximately one third of patients still do not receive pain medication proportional to their pain intensity.
A randomized study of lung cancer screening with spiral
Maurizio Infante,Silvio Cavuto,Fabio Romano Lutman,G Chiesa,Giovanni Luca Ceresoli,Eliseo Passera,Enzo Angeli,Maurizio Chiarenza,Giuseppe Aranzulla,Umberto Cariboni,Valentina Errico,Francesco Inzirillo,Edoardo Bottoni,Marco Alloisio,Anna Destro,Massimo Roncalli,Armando Santoro,Gianluigi Ravasi +17 more
TL;DR: The mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.
Journal Article
Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology
Nicolino Ruperto,Angelo Ravelli,Angela Pistorio,Clara Malattia,Silvio Cavuto,L Gado-West,A Tortorelli,J M Landgraf,G Singh,Alberto Martini +9 more
TL;DR: The results of the present study show that cross-cultural adaptation is a valid process to obtain reliable instruments for the different socio-economic and socio-demographic conditions of the countries participating in the project.
Journal ArticleDOI
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.
Maurizio Infante,Silvio Cavuto,Fabio Romano Lutman,Giorgio Brambilla,G Chiesa,Giovanni Luca Ceresoli,Eliseo Passera,Enzo Angeli,Maurizio Chiarenza,Giuseppe Aranzulla,Umberto Cariboni,Valentina Errico,Francesco Inzirillo,Edoardo Bottoni,Emanuele Voulaz,Marco Alloisio,Anna Destro,Massimo Roncalli,Armando Santoro,Gianluigi Ravasi +19 more
TL;DR: In this paper, the authors explored the effect of screening with low-dose spiral computed tomography (LDCT) on lung cancer mortality and found that the mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.